» Articles » PMID: 33708214

New Insights Into the Cancer-Microbiome-Immune Axis: Decrypting a Decade of Discoveries

Overview
Journal Front Immunol
Date 2021 Mar 12
PMID 33708214
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

The past decade has witnessed groundbreaking advances in the field of microbiome research. An area where immense implications of the microbiome have been demonstrated is tumor biology. The microbiome affects tumor initiation and progression through direct effects on the tumor cells and indirectly through manipulation of the immune system. It can also determine response to cancer therapies and predict disease progression and survival. Modulation of the microbiome can be harnessed to potentiate the efficacy of immunotherapies and decrease their toxicity. In this review, we comprehensively dissect recent evidence regarding the interaction of the microbiome and anti-tumor immune machinery and outline the critical questions which need to be addressed as we further explore this dynamic colloquy.

Citing Articles

Intratumoral microbiome: implications for immune modulation and innovative therapeutic strategies in cancer.

Wang N, Wu S, Huang L, Hu Y, He X, He J J Biomed Sci. 2025; 32(1):23.

PMID: 39966840 PMC: 11837407. DOI: 10.1186/s12929-025-01117-x.


Role of bacteria in cancers and their therapeutic potential: Review of current knowledge.

Wawrety W, Kedziora A Iran J Basic Med Sci. 2025; 28(3):273-282.

PMID: 39906620 PMC: 11790194. DOI: 10.22038/ijbms.2024.77667.16798.


Interaction of human gut microbiota and local immune system in progression of colorectal adenoma (MIMICA-1): a protocol for a prospective, observational cohort study.

Valciukiene J, Lastauskiene E, Laurinaviciene A, Jakubauskas M, Kryzauskas M, Valkiuniene R Front Oncol. 2025; 14():1495635.

PMID: 39834942 PMC: 11743970. DOI: 10.3389/fonc.2024.1495635.


Research progress on intratumoral microorganisms in renal cancer.

Zhang J, Lou K, Chi J, Wu J, Fan X, Cui Y World J Urol. 2025; 43(1):72.

PMID: 39812826 DOI: 10.1007/s00345-024-05403-5.


Microbiota and Cytokine Modulation: Innovations in Enhancing Anticancer Immunity and Personalized Cancer Therapies.

Rad H, Tahmasebi H, Javani S, Hemati M, Zakerhamidi D, Hosseini M Biomedicines. 2025; 12(12.

PMID: 39767682 PMC: 11673251. DOI: 10.3390/biomedicines12122776.


References
1.
Feng Q, Liang S, Jia H, Stadlmayr A, Tang L, Lan Z . Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat Commun. 2015; 6:6528. DOI: 10.1038/ncomms7528. View

2.
Holtmeier W, Kabelitz D . gammadelta T cells link innate and adaptive immune responses. Chem Immunol Allergy. 2005; 86:151-183. DOI: 10.1159/000086659. View

3.
Aykut B, Pushalkar S, Chen R, Li Q, Abengozar R, Kim J . The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL. Nature. 2019; 574(7777):264-267. PMC: 6858566. DOI: 10.1038/s41586-019-1608-2. View

4.
Veldhoen M, Uyttenhove C, Van Snick J, Helmby H, Westendorf A, Buer J . Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol. 2008; 9(12):1341-6. DOI: 10.1038/ni.1659. View

5.
Pushalkar S, Hundeyin M, Daley D, Zambirinis C, Kurz E, Mishra A . The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. Cancer Discov. 2018; 8(4):403-416. PMC: 6225783. DOI: 10.1158/2159-8290.CD-17-1134. View